Earnings Reports

Found 58,707 articles

• Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20

  1/18/2019

  Bausch Health Companies Inc. will release its fourth-quarter and full-year 2018 financial results on Wednesday, Feb. 20, 2019.

• Varex Schedules First Quarter Fiscal Year 2019 Earnings Release And Conference Call

  1/17/2019

  The earnings news release will be followed by a conference call available to all interested parties at 3:00 pm MT that day.

• Welltower Announces Date of Fourth Quarter 2018 Earnings Release, Conference Call and Webcast

  1/17/2019

  Welltower Inc. today announced that it will release its fourth quarter 2018 financial results before the market opens on February 12, 2019.

• Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference Call

  1/17/2019

  A conference call has been scheduled to discuss this information on Wednesday, February 13th, at 8:30 a.m. ET.

• QIAGEN N.V. to Report Fourth Quarter and Full Year 2018 Results

  1/17/2019

  QIAGEN N.V. plans as previously announced to release its report on results for the fourth quarter 2018 on Monday, February 4 at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EST).

• BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

  1/17/2019

  - Preliminary reported revenues of $4.160 billion increased 35.1 percent. - On a comparable, currency-neutral basis, preliminary revenues increased 5.2 percent. - As reported, preliminary diluted earnings per share of $2.05 increased 369.7 percent. - As adjusted, preliminary diluted earnings per share of $2.70 increased 8.9 percent, or 14.9 percent on a currency-neutral basis. - The company reaffirms previously issued fiscal year 2019 revenue and adjusted

• Adocia confirms its financial calendar for 2019

  1/16/2019

  Adocia confirmed its financial calendar for 2019 with a change in date of the annual shareholder’s meeting.

• LabCorp to Announce Fourth Quarter and Full Year 2018 Financial Results on February 7, 2019

  1/16/2019

  The earnings release and accompanying financial information will be posted on the LabCorp Investor Relations website.

• Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results

  1/16/2019

  Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 5, 2019, at 8:00 a.m. CST to review second quarter 2019 financial results.

• Dental Biomaterials Market to Grow at a CAGR of 4.4% through 2026

  1/16/2019

  The growing edentulous population is expected to be an important factor driving the growth of the global dental biomaterials market throughout the forecast period as people aged 60 years and above are at a high risk of developing dental disorders

• Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum

  1/16/2019

  The Medicrea Group announced full year 2018 sales.

• Universal Health Services, Inc. Announces Dividend Payable on March 15, 2019

  1/16/2019

  Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.10 per share on March 15, 2019 to shareholders of record as of March 1, 2019.

• Middlefield Healthcare & Life Sciences Announces First Quarter Distribution Schedule as an Active ETF

  1/16/2019

  Middlefield Healthcare & Life Sciences Dividend Fund is pleased to announce that distributions for the first quarter of 2019 will be payable to unitholders of Middlefield Healthcare & Life Sciences Dividend Fund

• 

  Your Feedback Matters! Topics in 2019

  1/15/2019

  As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about.

• Canopy Growth to Announce Third Quarter Fiscal 2019 Financial Results

  1/15/2019

  Canopy Growth will release its financial results for the third quarter fiscal 2019 ended December 31, 2018 after financial markets close on February 14, 2019.

• Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results

  1/15/2019

  Conference Call and Webcast Scheduled for Tuesday, February 5

• Illumina to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Tuesday, January 29, 2019

  1/15/2019

  Illumina today announced that it will issue results for fourth quarter and fiscal year 2018 following the close of market on Tuesday, January 29, 2019.

• Oramed Pharmaceuticals' CEO Letter to Shareholders

  1/15/2019

  We opened the year 2019 with the announcement of our receipt of a $3 million milestone payment from our partners HTIT, thereby increasing our total payments from HTIT received to date to $33 million.

• CLINIGEN GROUP Half Year trading update

  1/15/2019

  Revenues increased by around 24% on a reported basis and by around 25% on a constant currency basis* compared to last year.

• Central Logic Marks 2018 as Year of Robust Revenue Growth, Increased Client Acquisition Rates, and Pivotal Additions to Leadership Team

  1/15/2019

  Transfer center solution company continues to pioneer patient transfers, enabling its expanding roster of clients to reach their financial and clinical goals